外貿協會::五金展

ACRO BIOMEDICAL CO., LTD.

3F, No.57, Luke 2nd Rd., Lujhu Dist, Kaohsiung City 82151, Taiwan

About us

Our Mission

ACRO Biomedical thrives to improve the health benefit of patients by providing with the unmet clinical need. We employ the most advanced technology in the biomedical field to ensure the utmost safety and efficacy of our medical products.

 

Company Profile

ACRO Biomedical was founded in June 2014 and positioned to develop and produce biomaterial medical devices for human tissue engineering and regenerative medicine (TERM). ACRO Biomedical uses its proprietary supercritical CO₂ extraction technology to remove cells, fat, and non-collagenous proteins from animal tissues and organs, while leaving the intact collagen scaffolds as the biomaterial for high-end medical devices in the field of wound care, orthopedics, dentistry, ophthalmology, aesthetic microsurgery, cardiovascular, and neural surgery, etc.

 

Besides from the development of natural biomaterial scaffolds for tissue engineering, ACRO Biomedical has advanced in combining these tissue scaffolds with stem cells and/or somatic cells for human cell therapy in the field of skin regeneration and knee joint cartilage regeneration.

 

The ultimate goal for ACRO Biomedical is whole organ engineering for heart, liver, and kidney transplantation. We wish to recellularize the organ scaffold in vivo for autologous organ transplantation by grafting the decellularized natural organ scaffolds back into the live animal or human body.

 


 

 

 

Our Mission

ACRO Biomedical thrives to improve the health benefit of patients by providing with the unmet clinical need. We employ the most advanced technology in the biomedical field to ensure the utmost safety and efficacy of our medical products.

 

Company Profile

ACRO Biomedical was founded in June 2014 and positioned to develop and produce biomaterial medical devices for human tissue engineering and regenerative medicine (TERM). ACRO Biomedical uses its proprietary supercritical CO₂ extraction technology to remove cells, fat, and non-collagenous proteins from animal tissues and organs, while leaving the intact collagen scaffolds as the biomaterial for high-end medical devices in the field of wound care, orthopedics, dentistry, ophthalmology, aesthetic microsurgery, cardiovascular, and neural surgery, etc.

 

Besides from the development of natural biomaterial scaffolds for tissue engineering, ACRO Biomedical has advanced in combining these tissue scaffolds with stem cells and/or somatic cells for human cell therapy in the field of skin regeneration and knee joint cartilage regeneration.

 

The ultimate goal for ACRO Biomedical is whole organ engineering for heart, liver, and kidney transplantation. We wish to recellularize the organ scaffold in vivo for autologous organ transplantation by grafting the decellularized natural organ scaffolds back into the live animal or human body.

 

Products

ABCcolla™ Collagen Matrix

Product Description

ABCcolla™ Collagen Matrix is prepared by supercritical CO₂ extraction technology. It is a decellularized native porcine collagen scaffold dressing indicated for the management of full and partial-thickness wounds. The porous collagen bio-material absorbs a high level of wound exudates and maintains an optimal moist environment conducive to healing. The high degree of triple-helix nativity makes the dressing last longer in the wound. The 3D structure acts as an ECM-like scaffold, encouraging cell proliferation and migration, the formation of granulation tissue, and epithelialization to support the regeneration of human dermis and epidermis. It is completely bioabsorbable, so it does not need to be removed from the wound site.

 

Advantages

Excellent biocompatibility
Fast healing
Resorbable
Absorb exudates from the wounds and maintains the wound bed moisture

 

Indication

Ulcers
Burn wounds (first and second degree)
Trauma wounds
Surgical wounds
Diabetic wounds

ABCcolla™ Collagen Membrane

Product Description

ABCcolla Collagen Membrane is a decellularized porcine dermal sheet prepared by supercritical CO₂ extraction technology, which retains the native 3D scaffold structure of collagen with good mechanical strength that can withstand sutures during dental operations. It is bioabsorbable, biocompatible, non-toxic, non-irritating, and non-antigenic. It can be used as surgical wound covering in dental operations and functions as a barrier between soft and hard tissue. In addition, it provides space for efficient osteogenesis in the alveolar bone.

 

Advantages

No risk of BSE.
Very easy to handle and suture.
Great barrier between hard and soft tissue for up to 12 weeks.
Greatly absorbable hence eliminates second-stage surgery for membrane removal.

ABCcolla™ Collagen Bone Graft

Product Description

ABCcolla Collagen Bone Graft (Cancellous) is a decellularized native porcine bone graft material prepared by supercritical CO2 extraction technology, which is composed of native porcine collagen and bone matrix that are comparable to the human bone matrix. ABCcolla Collagen Bone Graft (Cancellous) is intended for filling and augmentation of bone voids or gaps during orthopedic surgeries. It facilitates cell attachment and improves bone regeneration and neovascularization. During the healing process, ABCcolla Collagen Bone Graft (Cancellous) gradually resorbs and is replenished by new bone.

 

Indication

Intended to fill bony voids or gaps
Traumatic bone injury
Osseous defects

ABCcolla™ Ophthalmic Matrix

Product Description

ABCcolla™ Collagen Ophthalmic Matrix is an acellular porcine cornea prepared by supercritical CO2 extraction technology, which consists of native corneal collagen scaffold. ABCcolla™ Collagen Ophthalmic Matrix is intended for cornea transplantation in replacement of human donated cornea. The native cornea collagen scaffold on ABCcolla™ Collagen Ophthalmic Matrix is suitable for limbo stem cells to migrate, attach, proliferate and differentiate into the right cell types and restore the full function of native cornea.

 

Indication

ABCcolla™ Collagen Ophthalmic Matrix is intended for the reconstruction of corneal structure.

 

Advantages

No BSE risk. 
Excellent bio-compatibility.
Various specifications for different wound width and depth types.
ISO10993 certified.
Excellent animal performance tests that showed great transparency

ABCcolla™ Collagen Dermal Filler

Product Description

ABCcolla™ Collagen Dermal Filler is a highly purified sterile injectable device, which is composed of atelo-collagen slurry and decellularized dermal particles with natural collagen scaffold from porcine dermis. ABCcolla™ Collagen Dermal Filler is intended for correction of severe facial wrinkles, skin folds, and for lip and cheek soft tissue augmentation.

 

Indication

This product is intended for correction of mild to severe facial wrinkles, skin folds, restorations of fat loss, lip and cheek augmentation.